This week, most Americans are preparing to visit with family and friends, cook a big meal, and give thanks for all the things they have – things like happiness and good health. During this special time, we at the Institute for OneWorld Health would like to remind you to also think about those who are less fortunate; those who live in extreme poverty and do not have access to the medical treatment they need when they fall ill.

iOWH depends on the generous support of individuals all over the world to fulfill our mission of developing and providing access to safe, effective and affordable medicines for neglected diseases in the developing world. Please consider making a gift this holiday season and help us reach thousands of people afflicted by deadly yet preventable diseases – people like Dillip, a young Indian boy who, in 2003, was dying of Visceral Leishmaniasis (VL), an infectious disease transmitted by a sand fly that, if left untreated, is always fatal. Today, thanks to a safe and affordable treatment developed by iOWH, Dillip is a healthy and active teenager who loves playing cricket with his friends.

Please, visit www.oneworldhealth.org and make a gift today. It will truly make a difference!

OneWorld Health Launches Phase 4 Program of Paromomycin IM Injection in India
On November 7, 2007 we announced the initiation of a major Phase 4 pharmacovigilance and access program for the treatment of visceral leishmaniasis (VL) in India.  Working with the principal investigators who are experts in the treatment of kala-azar, and nongovernmental organization (NGO) partners, our Phase 4 Program will investigate the safety and efficacy of treatment of VL with Paromomycin IM Injection in progressively more rural areas in Bihar State. Bihar is the epicenter of the disease in India, with an estimated 250,000 people infected there each year. The first module of the program will enroll approximately 500 patients to provide additional safety data on Paromomycin IM Injection. Over the course of the three-year program, up to 1500 additional patients will be included in two subsequent access modules that will extend the network of treatment facilities, providers, and related logistics systems into the most rural areas of Bihar. This is an innovative access model for administering Paromomycin IM Injection that uses an outpatient setting to diagnose and treat impoverished patients and advanced data transmission technologies in the remote areas where VL is endemic. It is hoped that this access model will be transferable to other infectious diseases in the developing world.

Paromomycin IM Injection Honored as Product of the Year by BayBio Northern California's Life Sciences Association
Each year BayBio recognizes achievement and honors excellence in the life sciences industry in Northern California. This year, our first approved drug product Paromomycin IM Injection was honored as Product of the Year. Visit our homepage to see photos of the event.

Dr. Victoria Hale Elected to Membership in Institute of Medicine
of the National Academies
OneWorld Health’s founder, Chief Executive Officer and board chair, Victoria Hale, Ph.D., has been elected to membership in the Institute of Medicine of the National Academies. Members are elected through a highly selective process by the incumbent membership on the basis of professional achievement and of demonstrated interest, concern and involvement with problems and critical issues that affect the health of the public. Those elected to the Institute of Medicine’s membership have made major contributions to the advancement of the medical sciences, health care, and public health. Established in 1970 by the National Academy of Sciences, the Institute has become recognized as a national resource for independent, scientifically informed analysis and recommendations on human health issues. With their election, members make a commitment to devote a significant amount of volunteer time as members of IOM committees, which engage in a broad range of studies on health policy issues.

Recent articles featuring OneWorld Health appeared in the San Francisco Business Times and Glamour magazine. Visit our Media Page to read these and other articles about OneWorld Health.


The Institute for One World Health is growing and searching for passionate and talented industry professionals to help us fulfill our mission of developing safe, effective, and affordable new medicines for people with diseases of poverty in the developing world.

For a current listing of open positions in our San Francisco office please visit the employment page on our website.

back to top >